Page 15 - GALENIKA MEDICAL JOURNAL

Literatura 26. Di Costanzo L, Ayala F, Megna M, Gaudiello F, Patrì A, Balato N. The
risk of herpes zoster in the anti-TNF-α era: a case report and review
of the literature. J Dermatol Case Rep. 2013 Mar 30;7(1):1-4.
1. Bader MS. Herpes Zoster: Diagnostic, Therapeutic, and Preventive
Approaches, Postgraduate Medicine. 2013 Sep;125(5):78-91. 27. Fan L, Wang Y, Liu X, Guan X. Association between statin
use and herpes zoster: systematic review and meta-
2. Shaw J, Gershon AA. Varicella Virus Vaccination in the analysis. BMJ Open. 2019 Feb 13;9(2):e022897.
United States. Viral Immunol. 2018; 31(2):96-103.
28. Gross GE, Eisert L, Doerr HW, Fickenscher H, Knuf M, Maier P, et al.
3. Li Y, Zhu B. Genotyping of clinical varicella-zoster virus isolates collected S2k guidelines for the diagnosis and treatment of herpes zoster and
from Yunnan in Southwestern China. Biomed Rep. 2016 Feb;4(2):209-14. postherpetic neuralgia. J Dtsch Dermatol Ges. 2020 Jan;18(1):55-78.
4. Centers for Disease Control and Prevention. The Pink Book: 29. Kim YJ, Lee CN, Lee MS, Lee JH, Lee JY, Han K, et al. Recurrence
Epidemiology and Prevention of Vaccine-Preventable Diseases. Rate of Herpes Zoster and Its Risk Factors: a Population-based
14th ed.; 2021. Accessed February 2022 at: https://www. Cohort Study. J Korean Med Sci. 2018 Dec 20;34(2):e1.
cdc.gov/chickenpox/hcp/index.html#transmission.
30. Sampathkumar P, Drage LA, Martin DP. Herpes zoster (shingles) and
5. Arvin AM. Varicella-zoster virus. Clin Microbiol Rev. 1996;9(3):361-81. postherpetic neuralgia. Mayo Clin Proc. 2009 Mar;84(3):274-80.
6. Patil A, Goldust M, Wollina U. Herpes zoster: A Review of Clinical 31. Werner RN, Nikkels AF, Marinović B, Schäfer M, Czarnecka-Operacz
Manifestations and Management. Viruses. 2022 Jan 19;14(2):192. M, Agius AM, et al. European consensus-based (S2k) Guideline
on the Management of Herpes Zoster - guided by the European
7. McCrary ML, Severson J, Tyring SK. Varicella zoster Dermatology Forum (EDF) in cooperation with the European
virus. J Am Acad Dermatol. 1999;41(1):1-14. Academy of Dermatology and Venereology (EADV), Part 1:
8. Gershon AA, Breuer J, Cohen JI, Cohrs RJ, Gershon MD, Gilden D, et al. Diagnosis. J Eur Acad Dermatol Venereol. 2017 Jan;31(1):9-19.
Varicella zoster virus infection. Nat Rev Dis Primers. 2015 Jul 2;1:15016. 32. Vukelić D, Oroši Končić D, Prepolec J, Škrabić I, Šupe Parun A,
9. Kennedy PG, Rovnak J, Badani H, Cohrs RJ. A comparison of Skuhala T, et al. Clinical characteristics of hospitalized adults and
adolescents with herpes zoster in Croatia: more than 20 years of a
herpes simplex virus type 1 and varicella-zoster virus latency single-center experience. Croat Med J. 2020 Oct 31;61(5):401-9.
and reactivation. J Gen Virol. 2015; 96(Pt 7): 1581-602.
10. Harpaz R, van Hoek AJ. Point-Counterpoint: The Hope- 33. Bongers LD, Navarini A, Berger CT, Mueller SM. Complications and
Simpson Hypothesis and Its Implications Regarding an cost estimations in herpes zoster - a retrospective analysis at a Swiss
Effect of Routine Varicella Vaccination on Herpes Zoster tertiary dermatology clinic. Swiss Med Wkly. 2021 Dec 28;151:w30081.
Incidence. J Infect Dis. 2018 Sep 22;218(suppl_2):S57-S62. 34. Erskine N, Tran H, Levin L, Ulbricht C, Fingeroth J, Kiefe C,
11. Solomon BA, Kaporis AG, Glass AT, Simon SI, Baldwin HE. et al. A systematic review and meta-analysis on herpes
Lasting immunity to varicella in doctors study (L.I.V.I.D. zoster and the risk of cardiac and cerebrovascular
study). J Am Acad Dermatol. 1998 May;38(5 Pt 1):763-5. events. PLoS One. 2017 Jul 27;12(7):e0181565.
12. Guzzetta G, Poletti P, Del Fava E, Ajelli M, Scalia Tomba GP, 35. Pergam SA, Limaye AP; AST Infectious Diseases Community of
Practice. Varicella zoster virus (VZV) in solid organ transplant
et al. Hope-Simpson’s progressive immunity hypothesis recipients. Am J Transplant. 2009 Dec;9 Suppl 4(Suppl 4):S108-15.
as a possible explanation for herpes zoster incidence
data. Am J Epidemiol. 2013 May 15;177(10):1134-42. 36. Hoyt B, Bhawan J. Histological spectrum of cutaneous herpes
13. Gilden D, Mahalingam R, Nagel MA, Pugazhenthi S, Cohrs RJ. infections. Am J Dermatopathol. 2014 Aug;36(8):609-19.
Review: The neurobiology of varicella zoster virus infection. 37. King DH. History, pharmacokinetics, and pharmacology of
Neuropathol Appl Neurobiol. 2011 Aug;37(5):441-63. acyclovir. J Am Acad Dermatol. 1988 Jan;18(1 Pt 2):176-9.
14. Blair RJ. Varicella Zoster Virus. Pediatr Rev. 2019 Jul;40(7):375-7. 38. Nikkels AF, Snoeck R, Rentier B, Pierard GE. Chronic verrucous
15. Centers for Disease Control and Prevention.Yellow Book: Health varicella zoster virus skin lesions: clinical, histological, molecular and
therapeutic aspects. Clin Exp Dermatol. 1999 Sep;24(5):346-53.
Information for International Travel; 2020. Accessed February
2022. Available at: https://wwwnc.cdc.gov/travel/yellowbook/2020/ 39. Werner RN, Nikkels AF, Marinović B, Schäfer M, Czarnecka-Operacz
travel-related-infectious-diseases/varicella-chickenpox. M, Agius AM, et al. European consensus-based (S2k) Guideline
16. Schmid DS, Jumaan AO. Impact of varicella vaccine on varicella- on the Management of Herpes Zoster - guided by the European
zoster virus dynamics. Clin Microbiol Rev. 2010 Jan;23(1):202-17. Dermatology Forum (EDF) in cooperation with the European
Academy of Dermatology and Venereology (EADV), Part 2:
17. Lachiewicz AM, Srinivas ML. Varicella-zoster virus Treatment. J Eur Acad Dermatol Venereol. 2017 Jan;31(1):20-29.
post-exposure management and prophylaxis: A
review. Prev Med Rep. 2019 Nov 6;16:101016.
18. Hatsushika Y, Nii I, Taniguchi T. Varicella caused by airborne
transmission of a localised herpes zoster infection in
a family. BMJ Case Rep. 2021;14(9):e243217.
Konflikt interesa: Nema
19. Satyaprakash AK, Tremaine AM, Stelter AA, Creed R,
Ravanfar P, Mendoza N, et al. Viremia in acute herpes Primljeno: 07. 03. 2022.
zoster. J Infect Dis. 2009 Jul 1;200(1):26-32. Prihvaćeno: 29. 04. 2022.
20. Johnson BH, Palmer L, Gatwood J, Lenhart G, Kawai K, Acosta CJ. Onlajn: 30. 06. 2022.
Annual incidence rates of herpes zoster among an immunocompetent
population in the United States. BMC Infect Dis. 2015;15:502.
21. Bakker KM, Eisenberg MC, Woods R, Martinez ME. Exploring
the Seasonal Drivers of Varicella Zoster Virus Transmission and
Reactivation. Am J Epidemiol. 2021 Sep 1;190(9):1814-20.
22. Medić S, Petrović V, Milosević V, Lozanov-Crvenković Z, Brkić S,
Andrews N, et al. Seroepidemiology of varicella zoster virus infection
in Vojvodina, Serbia. Epidemiol Infect. 2018 Sep;146(12):1593-601.
23. John AR, Canaday DH. Herpes Zoster in the Older Adult.
Infect Dis Clin North Am. 2017 Dec;31(4):811-26.
24. Forbes HJ, Bhaskaran K, Thomas SL, Smeeth L, Clayton T, Langan
SM. Quantification of risk factors for herpes zoster: population
based case-control study. BMJ. 2014 May 13;348:g2911.
25. Marra F, Parhar K, Huang B, Vadlamudi N. Risk Factors
for Herpes Zoster Infection: A Meta-Analysis. Open
Forum Infect Dis. 2020 Jan 9;7(1):ofaa005.

REVIJALNI RADOVI Galenika Medical Journal, 2022; 1(2):8-15. 15